{
    "Trade/Device Name(s)": [
        "Immunalysis Ethyl Alcohol Enzyme Assay"
    ],
    "Submitter Information": "Immunalysis Corporation",
    "510(k) Number": "K181553",
    "Predicate Device Reference 510(k) Number(s)": [
        "K032461"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DIC"
    ],
    "Summary Letter Date": "October 31, 2018",
    "Summary Letter Received Date": "September 20, 2018",
    "Submission Date": "September 19, 2018",
    "Regulation Number(s)": [
        "21 CFR 862.3040"
    ],
    "Regulation Name(s)": [
        "Alcohol test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Ethyl alcohol (Ethanol)"
    ],
    "Specimen Type(s)": [
        "Urine",
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Automated clinical chemistry analyzers",
        "Olympus AU400e analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme assay",
        "Spectrophotometry (340 nm)"
    ],
    "Methodologies": [
        "Enzymatic oxidation (alcohol dehydrogenase)"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Immunalysis Ethyl Alcohol Enzyme Assay for quantitative measurement of ethanol in urine, serum, or plasma using automated clinical chemistry analyzers.",
    "Indications for Use Summary": "For quantitative analysis of ethyl alcohol (ethanol) in human urine, serum, or plasma to aid in the diagnosis and treatment of alcohol intoxication and poisoning.",
    "fda_folder": "Toxicology"
}